TREATMENT OF DEEP MYCOSES WITH ITRACONAZOLE

被引：18

作者：

KUMAR, B

KAUR, I

CHAKRABARTI, A

SHARMA, VK

机构：

来源：

MYCOPATHOLOGIA | 1991年 / 115卷 / 03期

关键词：

ASPERGILLOSIS; CHROMOBLASTOMYCOSIS; ITRACONAZOLE; ZYGOMYCOSIS;

D O I：

10.1007/BF00462221

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Four patients with deep mycoses were treated with itraconazole. Two patients had chromoblastomycosis, one patient each had aspergillosis and Rhinofacial zygomycosis. These patients were either resistant to or showed poor response to Amphotericin B and/or ketoconazole. After the initial clinical and mycological evaluation, itraconazole was given in a daily dose of 200 mg orally. All patients responded to the drug very well. No adverse effects attributable to itraconazole were detected.

引用

页码：169 / 174

页数：6

共 13 条

[1]

BORELLI D, 1987, REV INFECT DIS S1, V91, P557

[2]

CRANER A, 1987, REV INFECT DIS S1, V9, P77

[3] INVITRO STUDIES WITH R-51,211 (ITRACONAZOLE) [J].

ESPINELINGROFF, A ;

SHADOMY, S ;

GEBHART, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) :5-9

[4]

LAVALLE P, REV INFECT DIS S1, V9, P564

[5]

MARICHAL P, 1984, J MED VET MYCOLOGY, V22, P13

[6]

PHILLIPS P, 1987, REV INFECT DIS S1, V9, P587

[7]

RENNING DW, 1989, AM J MED, V86, P791

[8]

Restrepo A, 1988, Ann N Y Acad Sci, V544, P504, DOI 10.1111/j.1749-6632.1988.tb40448.x

[9]

Rippon J. W., 1988, MED MYCOLOGY

[10]

SHARKEY PK, 1988, 28TH INT C ANT AG CH, P210

← 1 2 →